An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Treatment Gaining Popularity Online
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Express Worries
However, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in users injecting substances of uncertain source.
Several experts stated the popularity for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or prison.
Platform Reaction and Content Elimination
According to TikTok, the service has taken down violative content and prohibited associated keywords and search suggestions. The organization said it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for mixing or administering at residence.
After moments of entering one community, a vendor shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.
Item Details and Pricing
Within these communities, messages show black plastic packages with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram stated it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has previously seen individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose users to potentially serious health risks”.
